Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Two Distinct but Functionally Related Autoreactive T Cell Populations in Paroxysmal Nocturnal Hemoglobinuria and Idiopathic Aplastic Anemia: Glycosylphosphatidylinositol-Specific and IFNγ-Producing T Cells

Lucia Gargiulo, PhD, Michela Sica, PhD, Caterina Nannelli, BSc, Lucio Luzzatto, MD, Rosario Notaro, MD

Blood (2017) 130 (Supplement 1): 1166.

https://doi.org/10.1182/blood.V130.Suppl_1.1166.1166

Published: 2017

Journal Articles

Splenomegaly in Adolescents and Adults with Sickle Cell Anemia in Tanzania Is Associated with Less Severe Disease

Neema Budodi Lubuva, MD MMed, Venee N. Tubman, MD MMSc, Clara C Chamba, MD MMed, Erius Tebuka, MD MMed, Mbonea Yonazi, MD MMed, Furahini Tluway, MD MPH, Pius Magesa, MD MPath, Lucio Luzzatto, MD, Julie Makani, MD PhD FRCP, Magdalena Lyimo, MD PhD

Blood (2017) 130 (Supplement 1): 4793.

https://doi.org/10.1182/blood.V130.Suppl_1.4793.4793

Published: 2017

Journal Articles

Auto-Reactive Glycosyl-Phosphatidyl-Inositol (GPI) Specific T Cells Are Present in Most Patients with Idiopathic Aplastic Anemia (IAA)

Lucia Gargiulo, PhD, Yoshitaka Zaimoku, MD, Barbara Scappini, MD, Hiroyuki Maruyama, MD, Rie Ohumi, Lucio Luzzatto, MD, Shinji Nakao, MD PhD, Rosario Notaro, MD

Blood (2015) 126 (23): 2409.

https://doi.org/10.1182/blood.V126.23.2409.2409

Published: 2015

Journal Articles

Complement Activation in Paroxysmal Nocturnal Hemoglobinuria (PNH) Causes Oxidative Damage Which May Affect Response to Eculizumab

Michela Sica, PhD, Annamaria Pellecchia, PhD, Margherita Berardi, BS, Lucia Gargiulo, PhD, Tolulase A Olutogun, MD, Giovanni Caocci, MD, Giorgio La Nasa, MD, Maria De Angioletti, PhD, Lucio Luzzatto, MD FRCP, FRCPath, Rosario Notaro, MD

Blood (2014) 124 (21): 4397.

https://doi.org/10.1182/blood.V124.21.4397.4397

Published: 2014

Journal Articles

Autoreactive T Cells From Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Specifically Recognize Glycosyl- Phosphatidyl-Inositol (GPI)

Lucia Gargiulo, PhD, Michela Sica, PhD, Maria Papaioannou, MD, PhD, Giulia Talini, PhD, Aristeidis Chaidos, MD, PhD, Barbara Richichi, PhD, Andrei V Nikolaev, PhD, Cristina Nativi, PhD, Mark Layton, MD, Josu de la Fuente, MRCP, MRCPCH, FRCPath, Irene Roberts, Lucio Luzzatto, MD, FRCP, FRCPath, Rosario Notaro, MD, Anastasios Karadimitris, MD, PhD

Blood (2012) 120 (21): 647.

https://doi.org/10.1182/blood.V120.21.647.647

Published: 2012

Journal Articles

Genetic Polymorphism of the Complement Receptor-1 ( CR1 ) Gene Correlates with the Clinical Response to Eculizumab of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Tommaso Rondelli, BS, Antonio M. Risitano, MD, PhD, Régis Peffault de Latour, MD, Benedetta Peruzzi, PhD, Ricci Patrizia, BS, Wilma Barcellini, MD, Anna Paola Iori, Carla Boschetti, MD, Veronica Valle, MD, Veronique Frémeaux-Bacchi, PhD, Maria De Angioletti, PhD, Gerard Socie, Lucio Luzzatto, MD, FRCP, FRCPath, Rosario Notaro, MD

Blood (2012) 120 (21): 983.

https://doi.org/10.1182/blood.V120.21.983.983

Published: 2012

Journal Articles

Role of the Somatic Mutation Rate in Patients with Classical Myeloproliferative Neoplasms (MPN) with and without Other Neoplasms

Margherita Berardi, BS, Tommaso Rondelli, BS, Maria Chiara Susini, MD, Annamaria Pellecchia, BS, Elisabetta Antonioli, MD, Luca Boni, MD, Lucio Luzzatto, MD, FRCP, FRCPath, Alessandro M. Vannucchi, MD, Rosario Notaro, MD

Blood (2012) 120 (21): 5055.

https://doi.org/10.1182/blood.V120.21.5055.5055

Published: 2012

Journal Articles

Long Term Safety and Efficacy of Sustained Eculizumab Treatment In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Robert A Brodsky, MD, Carlos de Castro, III, MD, Hubert Schrezenmeier, MD, Professor, Antonio M. Risitano, MD, PhD, Joerg Schubert, MD, Jaroslaw P Maciejewski, MD, PhD, FACP, Ulrich Duehrsen, MD, Lucio Luzzatto, MD, FRCP, FRCPath, Petra Muus, MD, PhD, Jeffrey Szer, BMedSc, MBBS, FRACP, Gérard Socié, MD, PhD, Peter Hillmen, MBChB, FRCP, FRCPath, PhD

Blood (2010) 116 (21): 4237.

https://doi.org/10.1182/blood.V116.21.4237.4237

Published: 2010

Journal Articles

Thrombolytic Therapy for Reversal of Thrombosis In Paroxysmal Nocturnal Hemoglobinuria (PNH)

David J Araten, MD, Rosario Notaro, MD, Nancy A Kernan, MD, Farid Boulad, MD, Hugo Castro-Malaspina, MD, Trudy N Small, M.D, Andromachi Scaradavou, MD, Heather Magnan, MD, Susan E Prockop, MD, Sara Chaffee, MD, Jason Gonsky, MD, PhD, Raymond Thertulien, MD, PhD, Roberto Tarquini, MD, Lucio Luzzatto, MD

Blood (2010) 116 (21): 4239.

https://doi.org/10.1182/blood.V116.21.4239.4239

Published: 2010

Journal Articles

Effects of Eculizumab Therapy in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Concurrent Immunosuppressive Therapy for Bone Marrow Insufficiency.

Hubert Schrezenmeier, Joerg Schubert, MD, Lucio Luzzatto, MD, Petra Muus, MD, PhD, Gerard Socie, MD, PhD, Antonio M. Risitano, MD, PhD, Anita Hill, MBChB, (Hons), PhD, Peter Hillmen, MB, ChB, PhD

Blood (2009) 114 (22): 3012.

https://doi.org/10.1182/blood.V114.22.3012.3012

Published: 2009

Journal Articles

Significant Disease Burden in Paroxysmal Nocturnal Hemoglobinuria Patients with Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion: Clinical Improvement with Eculizumab Therapy.

Monica Bessler, MD, PhD, Hubert Schrezenmeier, MD, Jaroslaw P. Maciejewski, MD PhD, Anita Hill, MB ChB, Scott A. Rollins, PhD, Neal S. Young, MD, Lucio Luzzatto, MD

Blood (2007) 110 (11): 840.

https://doi.org/10.1182/blood.V110.11.840.840

Published: 2007

Journal Articles

The Terminal Complement Inhibitor Eculizumab Reduces Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Peter Hillmen, MB, PhD, Petra Muus, MD, PhD, Ulrich Dührsen, DM, Antonio M. Risitano, MD, PhD, Jörg Schubert, MD, Neal S. Young, MD, Hubert Schrezenmeier, MD, Jeffrey Szer, MB, BS, Robert A. Brodsky, MD, Anita Hill, MB, MD, Gérard Socié, MD, PhD, Scott A. Rollins, PhD, Russell P. Rother, PhD, Leonard Bell, MD, Lucio Luzzatto, MD

Blood (2006) 108 (11): 123.

https://doi.org/10.1182/blood.V108.11.123.123

Published: 2006

NARROW

Two Distinct but Functionally Related Autoreactive T Cell Populations in Paroxysmal Nocturnal Hemoglobinuria and Idiopathic Aplastic Anemia: Glycosylphosphatidylinositol-Specific and IFNγ-Producing T Cells

Splenomegaly in Adolescents and Adults with Sickle Cell Anemia in Tanzania Is Associated with Less Severe Disease

Auto-Reactive Glycosyl-Phosphatidyl-Inositol (GPI) Specific T Cells Are Present in Most Patients with Idiopathic Aplastic Anemia (IAA)

Complement Activation in Paroxysmal Nocturnal Hemoglobinuria (PNH) Causes Oxidative Damage Which May Affect Response to Eculizumab

Autoreactive T Cells From Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Specifically Recognize Glycosyl- Phosphatidyl-Inositol (GPI)

Genetic Polymorphism of the Complement Receptor-1 ( CR1 ) Gene Correlates with the Clinical Response to Eculizumab of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Role of the Somatic Mutation Rate in Patients with Classical Myeloproliferative Neoplasms (MPN) with and without Other Neoplasms

Long Term Safety and Efficacy of Sustained Eculizumab Treatment In Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Thrombolytic Therapy for Reversal of Thrombosis In Paroxysmal Nocturnal Hemoglobinuria (PNH)

Effects of Eculizumab Therapy in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Concurrent Immunosuppressive Therapy for Bone Marrow Insufficiency.

Significant Disease Burden in Paroxysmal Nocturnal Hemoglobinuria Patients with Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion: Clinical Improvement with Eculizumab Therapy.

The Terminal Complement Inhibitor Eculizumab Reduces Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only